Curcumin, a natural, biologically active compound extracted from rhizomes of Curcuma species, has been shown to possess potent anti-inflammatory, anti-
tumor and anti-oxidative properties. The mechanism by which
curcumin initiates apoptosis remains poorly understood. In the present report we investigated the effect of
curcumin on the activation of the apoptotic pathway in human renal Caki cells. Treatment of Caki cells with 50 microM
curcumin resulted in the activation of
caspase 3, cleavage of
phospholipase C-gamma1 and DNA fragmentation.
Curcumin-induced apoptosis is mediated through the activation of
caspase, which is specifically inhibited by the
caspase inhibitor, benzyloxycarbony-Val-
Ala-Asp-fluoromethyl
ketone.
Curcumin causes dose-dependent apoptosis and DNA fragmentation of Caki cells, which is preceded by the sequential dephosphorylation of Akt, down-regulation of the anti-apoptotic Bcl-2, Bcl-XL and IAP
proteins, release of
cytochrome c and activation of
caspase 3.
Cyclosporin A, as well as
caspase inhibitor, specifically inhibit
curcumin-induced apoptosis in Caki cells. Pre-treatment with N-acetyl-
cysteine, markedly prevented dephosphorylation of Akt, and
cytochrome c release, and cell death, suggesting a role for
reactive oxygen species in this process. The data indicate that
curcumin can cause cell damage by inactivating the Akt-related cell survival pathway and release of
cytochrome c, providing a new mechanism for
curcumin-induced cytotoxicity.